Associate Professor Clare Scott
Walter and Eliza Hall Institute
I lead an ovarian cancer laboratory focused on developing targeted therapies for ovarian cancer. Our aim is to change the current treatment paradigm of "one size fits all" for women with ovarian cancer. This involves the use of novel pre-clinical models of epithelial ovarian cancer, complementing my activities as a medical oncologist in breast and ovarian cancer.
We focus on designing novel treatments targeted to specific molecules that are altered in epithelial ovarian cancer, with an emphasis on unraveling causes of drug resistance.
Find out more about Clare:
Keeping one step ahead of cancer is Clare’s motivational drive. Her ambition is to apply insights fast emerging from blood models to understand solid tumours. Find out more about Clare's inspiring work here.